Galapagos to host its R&D Update 2022 in New York on 4 November 2022
17 Ottobre 2022 - 7:30AM
Mechelen, Belgium; 17
October 2022,
07.30
CET; - Galapagos NV
(Euronext & NASDAQ: GLPG) today announced that
it will host its R&D Day 2022 for analysts, investors and
financial press on Friday, 4 November
2022.
The live event will take place at the Yale Club
in New York City from 8:00 am to 10:30 am EDT (13.00 to 15.30 CET).
The event will feature presentations by key opinion leaders (KOLs)
and management on the company’s strategic objectives, scientific
pipeline and commercial progress. The company will also discuss its
third quarter financial results, which are scheduled to be
published on 3 November 2022.
A live webcast of the event will be accessible
through the Investor Center on the company’s website and will be
available for replay following the event. Interested parties can
register for the webcast utilizing the following link: webcast
registration, and participate in the Q&A by telephone
conference via the following link: telephone conference
registration.
About
GalapagosGalapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to Phase 4 programs in inflammation, oncology, fibrosis,
and other indications. Our first medicine for rheumatoid arthritis
and ulcerative colitis is available in the European Union, Norway,
Great Britain, and Japan. For additional information, please visit
www.glpg.com or follow us
on LinkedIn or Twitter.
ContactGalapagos R&D
Update 2022 Contact:Melody CareyPresident
and CEORx Communications Group, LLCmcarey@rxir.com
Investors:Sofie Van GijselHead of Investor
Relations+1 781 296 1143
Sandra CauwenberghsDirector Investor Relations+32 495 58 46
63ir@glpg.com
Media:Marieke VermeerschHead of Corporate
Communication+32 479 490 603media@glpg.com
Forward-looking statements
This release may contain forward-looking
statements. Such forward-looking statements are not guarantees of
future results. These forward-looking statements speak only as of
the date of publication of this document. Galapagos expressly
disclaims any obligation to update any forward-looking statements
in this document, unless specifically required by law or
regulation.
- Galapagos to host its R&D Update 2022 in New York on 4
November 2022
Grafico Azioni Galapagos (EU:GLPG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Galapagos (EU:GLPG)
Storico
Da Apr 2023 a Apr 2024